TITLE

CoryneRegNet: An ontology-based data warehouse of corynebacterial transcription factors and regulatory networks

AUTHOR(S)
Baumbach, Jan; Brinkrolf, Karina; Czaja, Lisa F; Rahmann, Sven; Tauch, Andreas
PUB. DATE
January 2006
SOURCE
BMC Genomics;2006, Vol. 7, p24
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The application of DNA microarray technology in post-genomic analysis of bacterial genome sequences has allowed the generation of huge amounts of data related to regulatory networks. This data along with literature-derived knowledge on regulation of gene expression has opened the way for genome-wide reconstruction of transcriptional regulatory networks. These large-scale reconstructions can be converted into in silico models of bacterial cells that allow a systematic analysis of network behavior in response to changing environmental conditions. Description: CoryneRegNet was designed to facilitate the genome-wide reconstruction of transcriptional regulatory networks of corynebacteria relevant in biotechnology and human medicine. During the import and integration process of data derived from experimental studies or literature knowledge CoryneRegNet generates links to genome annotations, to identified transcription factors and to the corresponding cis-regulatory elements. CoryneRegNet is based on a multi-layered, hierarchical and modular concept of transcriptional regulation and was implemented by using the relational database management system MySQL and an ontology-based data structure. Reconstructed regulatory networks can be visualized by using the yFiles JAVA graph library. As an application example of CoryneRegNet, we have reconstructed the global transcriptional regulation of a cellular module involved in SOS and stress response of corynebacteria. Conclusion: CoryneRegNet is an ontology-based data warehouse that allows a pertinent data management of regulatory interactions along with the genome-scale reconstruction of transcriptional regulatory networks. These models can further be combined with metabolic networks to build integrated models of cellular function including both metabolism and its transcriptional regulation.
ACCESSION #
28858601

 

Related Articles

  • Overcoming Limitations of Microarrays for Gene Expression Analysis. Janssen, Deb // Genomics & Proteomics;Apr2002, Vol. 2 Issue 3, p38 

    Focuses on different approaches and technologies for identifying changes in gene expression analysis in the U.S. Features of GeneSystem320, a gene expression system from Capital Genomix; Design of the DNA microarrays; Development of Hybrid Capture technology by Digene Corp.

  • Gene Expression Profiling of Human Diseases by Serial Analysis of Gene Expression. Shui Qing Ye, Edmund C.; Usher, David C.; Zhang, Li Q. // Journal of Biomedical Science;2002, Vol. 9 Issue 5, p384 

    Until recently, the approach to understanding the molecular basis of complex syndromes such as cancer, coronary artery disease, and diabetes was to study the behavior of individual genes. However, it is generally recognized that expression of a number of genes is coordinated both spatially and...

  • An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer. Min Xu; Kao, Ming-Chih J.; Nunez-Iglesias, Juan; Nevins, Joseph R.; West, Mike; Xianghong Jasmine Zhou // BMC Genomics;2008 Supplement 1, Vol. 9, Special section p1 

    Background: The most common application of microarray technology in disease research is to identify genes differentially expressed in disease versus normal tissues. However, it is known that, in complex diseases, phenotypes are determined not only by genes, but also by the underlying structure...

  • Comparison of the latest commercial short and long oligonucleotide microarray technologies. Reynies, Aurelien de; Geromin, Daniela; Cayuela, Jean-Michel; Petel, Fabien; Dessen, Philippe; Sigaux, Francois; Rickman, David S // BMC Genomics;2006, Vol. 7, p51 

    Background: We compared the relative precision and accuracy of expression measurements obtained from three different state-of-the-art commercial short and long-oligonucleotide microarray platforms (Affymetrix GeneChipâ„¢ , GE Healthcare CodeLinkâ„¢ and Agilent Technologies). The design...

  • Developmental disturbances in early life stage mortality (M74) of Baltic salmon fry as studied by changes in gene expression. Vuori, Kristiina AM; Koskinen, Heikki; Krasnov, Aleksei; Koivumaki, Paula; Afanasyev, Sergey; Vuorinen, Pekka J; Nikinmaa, Mikko // BMC Genomics;2006, Vol. 7, p56 

    Background: We have studied alterations of gene expression associated with naturally-occurring early life stage mortality (M74) in Baltic salmon using a cDNA microarray and real time PCR. M74- affected fry have several typical neurological, cardiovascular and pathological symptoms. They are also...

  • The molecular portraits of breast tumors are conserved across microarray platforms. Hu, Zhiyuan; Fan, Cheng; Oh, Daniel S; Marron, JS; He, Xiaping; Qaqish, Bahjat F; Livasy, Chad; Carey, Lisa A; Reynolds, Evangeline; Dressler, Lynn; Nobel, Andrew; Parker, Joel; Ewend, Matthew G; Sawyer, Lynda R; Wu, Junyuan; Liu, Yudong; Nanda, Rita; Tretiakova, Maria; Ruiz Orrico, Alejandra; Dreher, Donna // BMC Genomics;2006, Vol. 7, p96 

    Background: Validation of a novel gene expression signature in independent data sets is a critical step in the development of a clinically useful test for cancer patient risk-stratification. However, validation is often unconvincing because the size of the test set is typically small. To...

  • Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. Therese Sorlie; Yulei Wang; Chunlin Xiao; Hilde Johnsen; Bjorn Naume; Raymond R Samaha; Anne-Lise Borresen-Dale // BMC Genomics;2006, Vol. 7, p127 

    Background: Gene expression profiling has been used to define molecular phenotypes of complex diseases such as breast cancer. The luminal A and basal-like subtypes have been repeatedly identified and validated as the two main subtypes out of a total of five molecular subtypes of breast cancer....

  • Microarray analysis of defined Mycobacterium tuberculosis populations using RNA amplification strategies. Waddell, Simon J.; Laing, Ken; Senner, Claire; Butcher, Philip D. // BMC Genomics;2008, Vol. 9, Special section p1 

    Background: The amplification of bacterial RNA is required if complex host-pathogen interactions are to be studied where the recovery of bacterial RNA is limited. Here, using a whole genome Mycobacterium tuberculosis microarray to measure cross-genome representation of amplified mRNA...

  • DNA Microarrays in Clinical Cancer Research. Wadlow, Raymond; Ramaswamy, Sridhar // Current Molecular Medicine;Feb2005, Vol. 5 Issue 1, p111 

    The recent sequencing of the human genome, coupled with advances in biotechnology, is enabling the comprehensive molecular “profiling” of human tissues. In particular, DNA microarrays are powerful tools for obtaining global views of human tumor gene expression. Complex information...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics